Metabolic Effects of Low-Dose Insulin Therapy on Glucose Metabolism in Diabetic Ketoacidosis
The DOI matches its Crossref record.
Abstract
The effect of low-dose insulin treatment (5–10 U/h) on hepatic glucose production (HGP) and peripheral glucose disposal was determined in 5 insulindependent diabetes mellitus (IDDM) subjects who were admitted with diabetic ketoacidosis (DKA; plasma glucose 598 ± 50 mg/dl, blood pH 7.20 ± 0.06, plasma bicarbonate 12 ± 2 meq/L). Basal hepatic glucose production (4.3 ± 0.5 mg · kg1 min1) in the DKA patients was 1.5- to 2-fold greater (P < .01) than in controls (2.1 ± 0.1 mg · kg−1 · min−1) and nonketotic IDDM subjects (2.9 ± 0.3 mg · kg−1 · min−1), whereas tissue glucose disposal was significantly reduced (1.7 ± 0.1 vs. 2.1 ± 0.1 mg kg−1 min−1 P < .05). After the institution of insulin therapy (1 mU · kg−1 · min−1), the plasma glucose concentration fell at the rate of 60 ± 5 mg· dl−1 h−1 to reach a value of 220 ± 10 mg/dl, which was maintained constant for 2 h (insulinclamp technique). Blood pH (7.21 ± 0.06 to 7.35 ± 0.05) and plasma bicarbonate (12 ± 3 to 18 ± 2 meq\L) both increased during insulin therapy (P < .01). The decline in plasma glucose concentration during insulin therapy primarily resulted from a suppression of HGP (from 4.3 ± 0.5 to 1.7 ± 0.2 mg · kg−1 min−1 P < .01) and to a lesser extent from the stimulation of tissue glucose disposal (1.7 ± 0.2 to 2.6 ± 0.3 mg kg−1 min−1 P < .01). At this time, urine glucose excretion decreased from 2.6 ± 0.2 to 0.6 ± 0.1 mg kg−1 min−1. During the 2-h period of the insulin clamp (steady-state plasma glucose 220 ± 1 0 mg/dl, plasma free insulin 85 ± 5 (ill/ml), HGP in the DKA patients was further suppressed (1.70 ± 0.20 to 1.00 ± 0.20 mg · kg−1 min−11) but remained well above (P < .01) rates observed in control subjects (0.1 ± 0.02 mg · kg−1 · min−1) and nonketotic diabetic subjects (0.2 ± 0.1 mg · kg−1 · min−1). At the end of the 2-h insulin-clamp period, the rate of tissue glucose uptake (3.2 ± 0.3 mg kg−1 · min−1) had not increased significantly above the rate observed at the start of the clamp (2.6 ± 0.2 mg/kg). Urinary glucose losses during the insulin-clamp period averaged 0.10 ± 0.01 mg · kg−1 · min−1. In summary, in DKA, 1) hyperglycemia results from both a markedly increased rate of HGP and a modest decrease in tissue glucose uptake, 2) the ability of insulin to suppress HGP and to stimulate tissue glucose uptake is severely impaired, and 3) during the initial 6-h period of insulin therapy, urinary glucose losses (0.4 mg kg−1 min−1), stimulation of tissue glucose uptake (increment 1.5 mg kg−1 min−1), and suppression of HGP (decrement 3.3 mg · kg−1 · min−1) all contributed to the decline in plasma glucose. However, from the quantitative standpoint, inhibition of HGP is the most important determinant in the decline in plasma glucose concentration after institution of insulin therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
Management of Hyperglycemic Crises in Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., Barrett, E. J., Kreisberg, R. A., Malone, J. I., & Wall, B. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.131 · Cited by 710
Self-citationWolfsdorf, J. I., Glaser, N., Agus, M., Fritsch, M., Hanas, R., Rewers, A., Sperling, M. A., & Codner, E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12701 · Cited by 710
Rosenstock, J., & Ferrannini, E. (2015) · Diabetes Care · doi:10.2337/dc15-1380 · Cited by 664
“Had insulin deficiency been more profounddas can happen in T1D patientsdor had carbohydrate availability been drastically restricted, this mild ketosis would have evolved toward ketoacidosis, with decreased blood pH and bicarbonate and increased anion gap (12).”
BackgroundInfluentialSelf-citationDiabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563
Metadata
- Authors
- Luzi, L., Barrett, E. J., Groop, L. C., Ferrannini, E., & DeFronzo, R. A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1988-11-01
- Volume
- 37
- Issue
- 11
- Pages
- 1470-1477
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2130213301
- Cited by
- 122
- References
- 0
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic Effects of Low-Dose Insulin Therapy on Glucose Metabolism in Diabetic Ketoacidosis. https://app.cochat.ai/papers/10.2337/diab.37.11.1470
- The paper
- Luzi, L., Barrett, E. J., Groop, L. C., Ferrannini, E., & DeFronzo, R. A. (1988). Metabolic Effects of Low-Dose Insulin Therapy on Glucose Metabolism in Diabetic Ketoacidosis. Diabetes. https://doi.org/10.2337/diab.37.11.1470
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.